INTERPARFUMS, INC. ANNOUNCES FULL YEAR 2027 GUIDANCE
INTERPARFUMS INC (IPAR) filed an SEC Form 8-K — Regulation FD Disclosure. Exhibit 99.1 FOR IMMEDIATE RELEASE INTERPARFUMS, INC. ANNOUNCES FULL YEAR 2027 GUIDANCE New York, New York, November 18, 2026, Interparfums, Inc. (NASDAQ GS: IPAR) (“Interparfums” or the “Company”) today announced initial guidance for its fiscal year ending December 31, 2027. In
- Metric
- Net Sales
- Period
- fiscal year ending December 31, 2027
- New
- $1.58 billion
- Direction
- initiate
Facts are quoted from the filing text and checked against it.
How this was made
The 30-second read
Why it matters
The company provided 2027 net sales and diluted EPS targets, explicitly noting that 2027 does not assume the 2026 one-time IEEPA tariff-refund benefit.
Market read
Traders can update 2027 earnings expectations using the disclosed sales and EPS targets, while stress-testing the assumptions around FX, license phasing, and regional demand.
What to watch
The guidance assumes elevated brand investment and marketing to support 2027 blockbusters; margin durability could be questioned if launch timing or partner performance slips.
Background
Interparfums filed an 8-K with Regulation FD disclosure providing initial full-year 2027 guidance and commentary on blockbuster launches and licensing.
Ticker impact
Interparfums issued full-year 2027 guidance, targeting net sales of about $1.58B and diluted EPS of about $5.00.
Likely upward bias as the market prices in 2027 sales growth and higher normalized EPS, while monitoring FX and Middle East/Eastern Europe softness.
The filing discloses explicit 2027E net sales and diluted EPS targets, plus key offsets (no tariff-refund benefit in 2027, about 1% unfavorable FX impact, and regional challenges).
Market effects
Prestige fragrance licensing and blockbuster launch cadence remain key drivers; guidance may influence sentiment toward branded fragrance distributors.
Highlights ongoing challenges in the Middle East and Eastern Europe, which can affect regional demand expectations for luxury fragrance.
FX sensitivity (about 1% unfavorable impact assumed) reinforces that currency moves can swing reported results for global fragrance players.
Counterpoint
The EPS growth narrative is partly mechanical versus 2026’s one-time IEEPA tariff-refund gain, so investors may focus on whether underlying demand offsets license expirations and regional softness.
Key entities
- issuerInterparfums, Inc.
NASDAQ-listed fragrance company providing initial fiscal 2027 guidance in an 8-K Regulation FD disclosure.
- one-time itemIEEPA tariff refunds
A one-time gain included in 2026 estimated results, excluded from the 2027 guidance comparison.



